Whitepaper

Car-T Cell Therapy: A Journey From Challenges To Opportunities
Opportunities and Challenges in developing and marketing CAR-T: Will we have a cost-effective cure for cancer in the future?
CAR-T CELL THERAPY

More Whitepapers / Newsletters

ASCO Reveals: Increasing Options for Relapse/ Refractory Patients in Haematological Malignancies
ASCO Reveals: Increasing Optio...

Immunotherapies, a potentially life-saving therapy, have benefitted several patients suffering from cancer help to achieve complete remission that many other times, traditional chemotherapies fail to...

Idiopathic pulmonary fibrosis
Idiopathic pulmonary fibrosis

Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive form of interstitial lung disease (ILD), characterized by fibrosis and worsening lung function. It majorly affects the population older of...

Duchenne Muscular Dystrophy Newsletter
Duchenne Muscular Dystrophy

A genetic disorder, Duchenne Muscular Dystrophy (DMD), is a progressive form of muscular dystrophy with a higher preponderance in males; however, in some rare cases, it can occur in females too. As pe...

Cancer Anorexia Market
Cancer Anorexia

Anorexia is the loss of the desire to eat, whereas cachexia results from the skeletal muscle mass in excess because of the weight loss. The reason for Anorexia can be Cancer, AIDS, a mental disorder (...

Hospital-Acquired Bacterial Pneumonia/ Ventilator-Associated Bacterial Pneumonia
Hospital-Acquired Bacterial Pn...

Hospital-acquired bacterial pneumonia (HABP) is the most common type of health-care-associated infections (HAIs) and hospital-acquired infections. It is often seen in patients admitted to ICU wards. A...